[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Sunday 09 August 2020
Salford News Header Montage
Latest News:
RSS icon
Salford Lung Study Logo

Salford Lung Study - update

Recruitment going well and new website launched

Recruitment to the COPD part of the Salford Lung Study (SLS) has started to gather pace with 471 patients recruited by 41 GP sites across Salford so far.


The second trial, which is investigating the same investigational medicine for the treatment of asthma, has been reviewed by the MHRA and now has Ethics Committee approval.


The COPD trial has now moved into the main recruitment phase and the final GP practices will be opening to recruitment very soon. Julia O’Toole, the Community Team Director for the study, said: “We are getting closer to our goal of having 52 GP practices in Salford recruiting to the study which will obviously help with overall recruitment and give more patients access to the study.


“The current team are still very busy ensuring practices have the support and training they need to deliver the COPD part of the study. We have also been recruiting further research nurses, study facilitators and clinical research associates to help deliver the asthma study.”


To help support recruitment the study has launched a website – www.salfordlungstudy.co.uk – which provides prospective patients with more details about the study, including the inclusion and exclusion criteria and who to contact for more information.


Julia added: “We’ve had an excellent response from patients with COPD in Salford and the new website provides them with another way to find out more about the study and supports the information given by GPs and study staff.”


The Salford Lung Study is sponsored by GSK and is looking at the benefit that medicines bring to patients with COPD in the real world. It is a Phase IIIb effectiveness study that is bringing together a number of healthcare and research partners in a unique collaboration to ensure medicines which are being developed meet the needs of patients and healthcare systems.


SLS has brought GlaxoSmithKline (GSK), the study sponsor, together with GM CLRN, the Manchester Academic Health Science Centre (MAHSC), North West e-Health (NWeH), the University of Manchester, Salford Royal NHS Foundation Trust, NHS Salford, local GPs and community pharmacists. Half of the patients involved will receive GSK’s investigational medicine and the other half will remain on their existing therapies.